Biotechnology and Chemical Pharmaceutical Customer Partnership Meeting
Tuesday, December 5, 2006
United States Patent and Trademark Office
Madison Auditirium South
The next meeting of the U.S. Patent and Trademark Office Biotechnology and Chemical Pharmaceutical Customer Partnership is scheduled for Tuesday, December 5, 2006 from 9:00 am to 4:30 pm.
This meeting is also available on-line. Participation is limited to the first 200 individual registrants; so, if you are interested in attending this meeting, please click on the link below to register:
The most recent quarterly meeting for the Biotechnology and Chemical Pharmaceutical Customer Partnership was held on September 13, 2006 at the U.S. Patent and Trademark Office. The Biotechnology and Chemical Pharmaceutical Customer Partnership is designed and developed to be a forum to share ideas, experiences, and insights between individual users and the USPTO. The USPTO does not intend to use these customer partnership groups to arrive at any consensus. Invitations to participate will indicate that individual opinions are sought, rather than a group consensus and that the meetings are intended to be informal in nature and have varying participants. These customer partnership groups are formed with full recognition of the USPTO's responsibility under the Federal Advisory Committee Act (FACA), and that these customer partnership groups are not established as FACA compliant committees.
We value our customers in obtaining feedback from individual participants is important in our efforts to continuously improve the quality of our products and services. Your willing participation is helpful in providing us with insights and experiences in this informal process to assist us.
For information of future meetings and presentations, please go to http://www.cabic.com/bcp/.
Please contact Cecilia Tsang at 571-272-0562, or by fax at 571-273-0562, or email Cecilia.Tsang@uspto.gov to decline or confirm your attendance by November 30, 2006.
Greetings and Overview
John LeGuyader, Bruce Kisliuk, George C. Elliott, Directors, Technology Center 1600
Office of Patent Quality
Discussion of claim examples for restriction
Bruce Campell Supervisory Patent Examiner, Art Unit 1648
Utility and written description and the impacts of Fisher and Capon
|Jeff Siew, Supervisory Patent Examiner, Art Unit 1642 & 1645|
|Johann Richter, Supervisory Patent Examiner, Art Unit 1616|
|Terry McKelvey, Supervisory Patent Examiner, Art Unit 1655|
|John LeGuyader, Bruce Kisliuk, George C. Elliott, Directors, TC 1600|